Wells Fargo Upgrades Globus Medical (GMED) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Globus Medical Reports Second Quarter 2016 Results
July 26, 2016 4:30 PM EDTAUDUBON, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016.
Worldwide sales increased 2.9% as reported to $137.5 million, or 3.1% on a constant currency basisSecond quarter net income increased 7.3% to $25.8 million, or 18.8% of salesDiluted earnings per share (EPS) increased 6.9% to $0.27Non-GAAP diluted EPS increased 10.6% to $0.29Non-GAAP Adjusted EBITDA (AEBITDA) was 36.5% of salesCompany issues new 2016 guidance for sales of $575 millionDavid Paul, Chairman and CEO said, Second quarter sales... More
